Síndrome de hiperestimulación ovárica: (SHO) Revisión del tema

Autores/as

  • E Otero Universidad Católica de Lovaina
  • S. Bassil Universidad Católica de Lovaina
  • S Gordts Universidad Católica de Lovaina
  • J. Donnez Universidad Católica de Lovaina

DOI:

https://doi.org/10.18597/rcog.1693

Resumen

Nuestro entendimiento de la fisiología de la ovulación continúa en progreso y desde la primera descripción de una inducción exitosa por Gemzell et al (1), muchos avances en el tratamiento han sido hechos.

Biografía del autor/a

E Otero, Universidad Católica de Lovaina

Servicio de Ginecología. Universidad Católica de Lovaina. Clínica Universitaria. St-Luc, Bruxellas- Bélgica

S. Bassil, Universidad Católica de Lovaina

Servicio de Ginecología. Universidad Católica de Lovaina. Clínica Universitaria. St-Luc, Bruxellas- Bélgica

S Gordts, Universidad Católica de Lovaina

Servicio de Ginecología. Universidad Católica de Lovaina. Clínica Universitaria. St-Luc, Bruxellas- Bélgica

J. Donnez, Universidad Católica de Lovaina

Servicio de Ginecología. Universidad Católica de Lovaina. Clínica Universitaria. St-Luc, Bruxellas- Bélgica

Referencias bibliográficas

Gemzell CA., Diczfalusy E., Tillinger G. Clinical effect of human pituitary follicle stimulating hormone (FSH). J. Clin. Endocrinol Metab. 1958; 18: 1333.

Schenker JG and Weinstein D. Ovarian hyperstimulation syndrome: a current survey. Fértil Steril 1978; 30: 255-268.

Schenker JG. Prevention and treatment of ovarian hyperstimulation. Review. Hum. Reprod. 1993; 8: 653-659.

Bilan FIVNAT. Réponses aux stimulations de l’ovulation dans les procréations médicalement assistées (PMA). Contracept Fértil Sex 1987; 18: 592-594.

Dahl CA., Wheeler CA, Frishman GN., Hackett RJ., Seifer DB., Haning RV Jr. Early and late presentation of the ovarian hyperstimulation syndrome: two distinct entities with different risk factors. Hum Reprod 1994; 9: 792-799.

Asch RH., Li HP., Balmaceda JP., Weckstein LN., Stone SC. Severe ovarian hyperstimulation syndrome in assisted reproductive technology: definition of high risk groups. Hum. Reprod. 1991; 6: 1395-1399.

Golan A., Weinraub Z., Ron ER., Soffer Y., Herman A., Caspi E. Ovarian hyperstimulation syndrome following D-Trp -6 luteinizing hormone - releasing hormone microcapsules and menotropin for In Vitro Fertilization. Fértil Steril 1988; 50: 912-916.

Padilla S., Zamaris S., Bramki T., García J. Abdominal paracentesis for the ovarian hyperstimulation syndrome with severe pulmonary compromise. Fértil Steril 1990; 53: 365-367.

Forman R., Ross C., Frydman R., Barlow D., Egan D. Severe ovarian Hyperstimulation syndrome using agonists of gonadotropin-releasing hormone for In Vitro Fertilization: a European series and a proposal for prevention. Fértil Steril 1990; 53: 502-509.

Haning RV Jr., Austin CW., Carlson IH., Kuzma DL., Shapiro S., Zweibel WJ. Plasma estradiol is superior to ultrasound and urinary estriol glycuronide as a predictor of ovarian hyperstimulation during induction of ovulation with menotropins. Fértil Steril 1983; 40: 31-36.

Tulandi T., Meinnes RA., Arronet GH. Ovarian hyperstimulation syndrome following ovulation induction with hMG. Int. J. Fértil 1984; 29: 113-117.

Delvigne A., Dubois M., Battheu B., Bassil S., Meuleman C., De Sutter P., Rodesh C., Janssens P., Remade P., Gordts S., Puttemans P., Joostens M., van Roosendael E., Leroy F. The ovarian hyperstimulation syndrome in In Vitro Fertilization: a Belgian multicentric study. II. Multiple discriminent analysis forrik prediction. Hum. Reprod. 1994; 8: 1361-1366.

Scommegna A., Lash SR. Ovarian overstimulation, massive ascites and singleton pregnancy after clomiphene. J. Am. Med. Assoc. 1969; 207: 753-758.

Southan AC., Janovsky NA. Massive ovarian hyperstimulation with clomiphene citrate. J. Am. Med. Assoc. 1962; 181: 443-447.

Morgan H., Paredes RA., Lachelin GCL. Severe ovarian hyperstimulation after clomiphene citarte in a hypothyroid patient. Case report Br. J. Obstet. Gynaecol. 1983; 90: 977-982.

Schriock ED., Jaffe RB. Induction of ovulation with gonadotrophin releasing hormone Obstet. Gynaecol. Surv. 1986; 41: 414-423.

Gompel A., Mauvais-Jarvis P. Induction of ovulation with pulsatile GnRH in hypothalamic amenorrhea. Hum. Reprod. 1988; 3:473-477.

Groot CA Lammers., JW., Hllanders JM. Asthma after ovarian hyperstimulation syndrome. Lancet 1991; 12: 337.

Delvigne A., Demoulin A., Smitz J., Donnez J., Koninckx P., Dhont M., Englert Y., Delbeke L., Darcis L., Gordts S., Puttemans P., Gerris J., Schoysman R., Leroy F. The ovarian hyperstimulation syndrome in In Vitro Fertilization: a Belgian multicentric study. I. Clinical and biological features. Hum. Reprod. 1993; 8: 1353-1360.

Check JH., Wu CH., Gocial B., Adelson HG. Severe ovarian hyperstimulation syndrome from treatment with urinary follicle stimulating hormone: two cases. Fértil Steril 1985; 43: 317-319.

Tyler E. Treatment of anovulation with metropins. J. Am. Med. Assoc. 1969; 205: 16-22.

Schenker JG., Yarkoni S., Grant M. Multiple pregnancies following induction of ovulation. Fértil Steril 1981; 35: 105-123.

Caspi E., Ron-El R., Golam A., Nachum H., Herman A., Soffer Y., Weinraub Z. Results of in vitro fertilization and embryo-transfer by combined long-acting gonadotropin releasing hormone analog D-Trp-6 luteinizing hormone-releasing hormone and gonadotropins. Fértil Steril 1989; 51: 95-99.

Mac Dougall MJ., Tan SL., Jacobs HS. In Vitro fertilization and the ovarian hyperstimulation syndrome. Hum. Reprod. 1992; 7: 597-600.

Rabau E., David A., Serr DM., Maschiach S., Lunenfeld B. Human menopausal gonadotropins for anovulation and sterility: results of 7 years of treatment. Am. J. Obstet. Gynaecol. 1967; 98: 92-98.

WHO Scientific Group. Agents stimulating gonadal functions in the human. Technical Report Series No. 154. Geneva: World Health Organization, 1973.

Golan A., Ron-El R., Herman A., Soffer Y., Weinraub Z., Caspi E. Ovarian hyperstimulation syndrome. An update review. Obstet. Gynaecol. Surv. 1989; 44: 430-440.

Navot D., Bergh PA., Laufer N. Ovarian hyperstimulation syndrome in novel reproductive technologies: prevention and treatment. Fértil Steril 1992; 58: 249-261.

Rizk B., Aboulghar MA., Mansour RT., Serour GL, Amin Y. Severe ovarian hyperstimulation syndrome, analytical study of twenty-one cases. Hum. Reprod. 6 (Suppl 1): 1991; 368-369.

Smitz J., Camus M., Devroey P., Erard P., Wisanto A., Van Steirteghem AC. Incidence of severe ovarian hyperstimulation syndrome after GnRH agonist/HM superovulation for in-vitro Fertilization. Hum. Reprod. 1990; 5: 933-937.

Schwartz M., Jewelewicz R. The use of gonadotropins for induction of ovulation. Fértil Steril 1981; 35: 3-12.

Mozes M., Bogowsky H., Anteby E., Lunenfeld B., Rabau E., Serr D., David A., Salmony M. Thromboembolic phenomena after ovarian stimulation with human menopausal gonadotrophins. Lancet ii, 1965; 1213-1215.

Glickman RM., Isselbacker KS. Abdominal swelling and ascites. In Petersdorf RL. and Adams RD (eds), Harrison principles of internal medicine. Mc Graw - Hill New York p. 209.

Robbins SL. Pathologic basis of diseases. Saunders Co. 9th edn. 1974; p. 1023.

Phillips LL., Gladstone W., van de Wiele R. Studies of the coagulation and fibrinolytic systems in hyperstimulation syndrome after administration of human gonadotropins. J. Reprod. Med. 1975; 14: 138-140.

Crooke AC., Butt WR., Palmer RF., Morris R., Edward RL., Anson CJ. Clinical trial of human gonadotropins. J. Obstet. Gynecol. Br. Common 1963; 70: 604-631.

Gemzell CA., Roos P., Loeffler E. Follicle stimulating hormone. In: SJ Behrman, RW Kistner(eds): Progress in infertility. Boston: Little, Brown and Co. 1975; 490.

Fournet N., Surrey E., Kerin J. Internal jugular vein thrombosis after ovulation induction with gonadotropins. Fértil Steril 1991; 56: 354-356.

Kaaja R., Sieberg R., Koskimies A. Severe ovarian hyperstimulation syndrome and deep venous thrombosis. Lancet ii, 1989; 1043.

Rizk B., Meagher S., Fisher AM. Severe ovarian hyperstimulation syndrome and cerebrovascular accidents. Hum Reprod. 1990; 5:697-698.

Mills MS., Eddowes HA., Fox R., Wardle PG. Subclavian vein thrombosis: a late complication of ovarian hyperstimulation syndrome Hum Reprod. 1992; 7: 370-371.

Demey HE., Delemans R., Galdermans D., Verpooten GA., De Broe ME., Bossaert LL. Acute oligo-anuria during ovarian hyperstimulation syndrome. Acta Obstet. Gynecol Scand 1987; 66: 741-743.

Balash J., Carmona F., Llach J., Arroyo V., Jové I., Vanrell J. Acute renal failure and liver dysfunction in a patient with severe ovarian hyperstimulation syndrome. Hum Reprod. 1990; 5: 348-351.

Ryley NG., Forman R., Barlow D., Fleming KA., Trowell JM. Liver abnormality in ovarian hyperstimulation syndrome. Hum. Reprod. 1990; 5: 938-943.

Sueldo CE., Price HM., Bachenberg K., Steinleitner A., Gitlin N., Swanson J. Liver dysfunction in ovarian hyperstimulation syndrome. A case report. J. Reprod. Med. 1988; 33: 387-390.

Younis JS., Zeevi D., Rabinowitz R., Laufer N., Schenker JG. Transient liver function tests abnormalities in ovarian hyperstimulation syndrome. Fértil Steril 1988; 50: 176-178.

Clive DM., Stoff JS. Renal syndromes associated with nonsteroidal anti-inflammatory drugs. N. Engl. J. Med. 1984; 310: 563-572.

Zosmer A., Katz Z., Lancet M., Konichezky S., Schwartz-Shoham Z. Adult respiratory distress syndrome complicating hyperstimulation syndrome ovarian. Fértil Steril 1987; 47: 524-527.

Tollan A., Holst N., Forsdahl F., Fadens HO., Oían P., Maltau JM. Transcapillary fluid dynamic during ovarian stimulation for in vitro fertilization. Am. J. Obstet. Gynecol. 1990; 162: 554-558.

Jacob W., Jentrsch KD, Maursberger B., Oehme P. Demonstration of angiogenesis activity in the corpus luteum of cattle. Exp Pathol 1977; 13: 231.

Yarali H., Fleige-Zahradka BG., Yuen BH., Me Comb PF. The ascites in the ovarian hyperstimulation syndrome does not originate from the ovary. Fértil Steril. 1993; 59: 657-661.

Polishuk WK., Schenker JG. Ovarian overstimulation syndrome. Fértil Steril 1969; 20: 443-450.

Schenker JG., Polishuk WZ. An experimental model of ovarian hyperstimulation syndrome. In: TischnerM., Pile J. (eds): Proceedings of the international Congress on Animal Reproduction. Vol. 4. Krakow: Drukamia Naukowa 1976; p. 635.

Balasch J., Arroyo V., Carmona F., Llach J., Jiménez W., Pare JC, Vanrell JA. Severe ovarian hyperstimulation syndrome: role of peripheral vasodilation. Fértil Steril 1991; 56: 1077-1083.

Davis JS. Hormonal control of plasma and erythrocyte volume of rat uterus. Am. J. Physiol 1960; 199: 841-846.

Navot D., Margalioth EJ., Laufer N., Birkenfeld A., Relon A., Rosier A., Schenker JG. Direct correlation between plasma renin activity and severity of ovarian hyperstimulation syndrome. Fértil Steril 1987; 48: 57-61.

Ong ACM., Eisen V., Rennie DP., Homburg R., Lachelin GCL., Jacobs HS., Slater JDH. The pathogenesis of the ovarian hyperstimulation syndrome (OHS): a possible role for ovarian renin. Clin Endocrinol 1991; 34: 43-49.

Haning RV Jr., Strawn EY., Nolten WE. Pathophysiology of the ovarian hyperstimulation syndrome. Obstet. Gynecol. 1985; 66: 220-224.

Montea E., Maraña R., Garcea N., Caruso S. Iatrogenic hyperstimulation of the ovary with ascites: report of a case and considerations and management. Acta Eur Fértil 1977; 8: 155-157.

Knox GE., Dowd A., Spiesel S., Hong R. Antihistamine blockade of the ovarian hyperstimulation syndrome. II. Possible role of antigen-antibody complexes in the pathogenesis of the syndrome. Fértil Steril 1975; 26: 418-421.

Gergly RZ., Paldi E., Erlik Y., Makler A. Treatment of ovarian hyperstimulation syndrome by antihistamine. Obstet. Gynecol. 1976; 47: 83-85.

Pride SM., Ho Yuen B., Moon YS. Clinical endocrinological and intra-ovarian prostaglandin-F response to H-1 receptor blockade in the ovarian hyperstimulation syndrome. Am. J. Obstet. Gynecol. 1984; 148: 670-674.

Erlik Y., Naot Y., Friedman M., Ben-David E., Paldi E. Histamine levels in ovarian hyperstimulation syndrome. Obstet. Gynecol. 1979; 53: 580-582.

Borenstein R., Elhalah U., Luchelfed B., Schwartz ZS. Severe ovarian hyperstimulation syndrome: a reevaluated therapeutic approach. Fértil Steril 1989;51:791-795.

Katz Z., Lancet M., Borenstein R., Chemke J. Absence of teratogenicity of indomethacin in ovarian hyperstimulation syndrome. Int. J. Fértil. 1984; 29: 186-188.

Schenker JG., Navot D. Complication of induction of ovulation. In Teoh ES:, Ratnam SS and Wong C. (eds): Ovulation and Early Pregnancy. The Parthenon Publishing Group, Carnforth, Lacashire 1987; p. 53.

Kirshon B., Doody M., Cotton D., Gibbons W. Management of ovarian hyperstimulation syndrome with chlorpheniramine maleate, mannitol and invasive hemodynamic monitoring. Obstet. Gynecol. 1988; 71: 485-487.

Aboulghar MA., Mansour RT., Serour GI., Amin Y. Ultrsonically guided vaginal aspiration of ascites in the treatment of severe ovarian hyperstimulation syndrome. Fértil Steril 1990; 53: 933-935.

García-Compean D., Pérez-Martínez L., Guerra JM., Barragán RF. Therapeutic paracentesis with albumin infusion for the treatment of tension ascites in cirrhotic patients. Rev. Gastroenterol. Mex. 1990; 55: 7-12.

Ferraretti AP., Gianaroli L., Diotallevi L., Festi C., Trounson A. Dopamine treatment for severe ovarian hyperstimulation syndrome. Hum. Reprod. 1992; 7: 180-183.

Kemmann E., Ghazi DM., Corson GH. Adnexal torsion in menotropin induced pregnancies. Obstet. Gynecol. 1990; 3: 403-406.

Mashiach S., Bider D., Moran O., Goldberg M., Ben-RafaelZ. Adnexal torsion of hypestimulated ovaries in pregnancies after gonadotropin therapy. Fértil Steril 1990; 53: 76-80.

Franks S., Mason HD., Polson DW., Winston RML., Margara R., Reed MJ. Mechanism and management of ovulatory failure in women with polycistic ovary syndrome. Hum. Reprod. 1988; 3: 531-544.

Mc Ardle C., Seibel M., Hann L., Weinstein F., Taymor M. The diagnosis of ovarian hyperstimulation (OHS): the impact of ultrasound. Fértil Steril 1983; 39: 464-467.

Belaisch-Allart J., Testart J., Belasich J., Frydman R., Hazout A. Selective ovocyte retrieval: a new approach to ovarian hyperstimulation. Fértil Steril 1988; 50: 654-656.

Ingerslev HJ. Selective follicular reduction following by exogenous gonadotrophins in polycystic ovarian disease. A new approach to treatment. Hum. Reprod. 1991; 6: 682-685.

Rabinowitz R., Laufer N., Lewin A., Schenker JG. Rate of ovarian hyperstimulation syndrome after high-dose HMG for induction of ovulation in IVF cycles. 5th Congress on IVF-ET. Norfolk, USA. Abstract 500 1987; 111.

Friedman CI, Schmidt GE., Chang FE., Kim MH. Severe ovarian hyperstimulation following follicular aspiration. Am. J. Obstet. Gynecol. 1984; 150: 436-437.

Wada I., Matson PL., Troup SA., Moroll D., Hunt L., Lieberman BA. Does elective cryopreservation of all embryos from women at risk of ovarian hyperstimuiation syndrome reduce the incidence of the condition. Br. J. Obstet. Gynecol. 1993; 100: 265-269.

Urman B., Pride SM., Yuen BH. Management of overstimulated gonadotrophin cycle with a controlled drift period. Hum. Reprod. 1992; 7: 213-217.

Salat-Baroux F., Alvarez S., Antoine JM., Comet D., Tibi C, Plachot M., Mandelbaum J. Treatment of hyperstimuiation during in vitro fertilization. Hum. Reprod. 1990; 5: 36-39.

Wada I, Matson PL., Horne G., Buck P., Lieberman BA. Is continuation of a gonadotrophin-releasing hormone agonist (GnRHa) necessary for women at risk of developing the ovarian hypeerstimulation syndrome? Hum. Reprod. 1992; 7: 1090-1093.

Crosignani PG., Trojsi L., Attanasio A., Tonani E., Donini P. Hormonal profiles in anovulatory patients treated with gonadotropins and synthetic luteinizing hormone releasing hormone. Obstet. Gynecol. 1975; 46: 15-22.

Itskowitz J., Boldes R., Levron J., Erlik Y., Kabana L., Brandes JM. Induction of preovulatory luteinizing hormone surge and prevention of ovarian hyperstimuiation syndrome by gonadotropin-releasing hormone agonist. Fértil Steril 1991; 56: 213-220.

Emperaire JC., Ruffie A. Triggering ovulation with endogenous luteinizing hormone may prevent the ovarian hyperstimuiation syndrome. Hum. Reprod. 1991; 6: 506-510.

Tan SL., Balen A., El Hussein E., Campbell S., Jacobs HS. The administration of glucocorticoids for prevention of ovarian hyperstimuiation syndrome in In vitro fertilization: a prospective randomized study. Fértil Steril 1992; 58: 378-383.

Shoham Z., Weissman A., Barash A., Borenstein R., Schachter M., Insler V. Intravenous albumin for the prevention of severe ovarian hyperstimuiation syndrome in In vitro fertilization program: a prospective, randomized, placebo-controlled study. Fértil Steril 1994; 62: 137-142.

Herman A., Ron-El R., Golan A., Raziel A., Soffer Y., Caspi E. Pregnancy rate and ovarian hyperstimuiation after luteal human chronic gonadotropin in In vitro fertilization stimulated with gonadotropin-releasing hormone analog and menotropins. Fértil Steril 1990;52:92-96.

Mc Clure N., Leya j., Radwanska E., Rawlins R., Haning RV jr. Luteal phase support and severe ovarian hyperstimuiation syndrome. Hum. Reprod. 1992; 7: 758-764.

Bassil S., Godin PA., Stallaert S., Nisolle M., Donnez J., Gordts S. Ovarian hyperstimuiation syndrome: do preventive measures work? Hum. Reprod. 9 (suppl 4). abs. 412. 1994; 156.

Cómo citar

1.
Otero E, Bassil S, Gordts S, Donnez J. Síndrome de hiperestimulación ovárica: (SHO) Revisión del tema. Rev. Colomb. Obstet. Ginecol. [Internet]. 29 de diciembre de 1995 [citado 6 de octubre de 2022];46(4):227-33. Disponible en: https://revista.fecolsog.org/index.php/rcog/article/view/1693

Descargas

Los datos de descargas todavía no están disponibles.

Descargas

Publicado

1995-12-29
Crossref Cited-by logo